Presentation is loading. Please wait.

Presentation is loading. Please wait.

Vaclav Kirsner, PhD, Founder CEO bioZhena Corporation (970) 484-1272 Transforming Female Reproductive Health.

Similar presentations


Presentation on theme: "Vaclav Kirsner, PhD, Founder CEO bioZhena Corporation (970) 484-1272 Transforming Female Reproductive Health."— Presentation transcript:

1

2 Vaclav Kirsner, PhD, Founder CEO bioZhena Corporation http://www.biozhena.com/ vaclav@biozhena.com (970) 484-1272 Transforming Female Reproductive Health Management Auguste Rodin, The Kiss Profits from the already FDA-cleared application of the Ovulona™ will support the introduction of the next applications

3 Prolog THIS SLIDE IS WITHOUT MY VOICE & WITHOUT AUTO-ADVANCE. CLICK TO ADVANCE OR USE NAVIGATION BUTTONS (BOTTOM LEFT) Broad electrometric applicability of the Ovulona™ There is solid precedent for observing differences between electrometric signatures of normal healthy cervical tissues (epithelia) and those of aberrant tissues (e.g. pre-cancerous CIN epithelia) “as significant as those obtained from analyzing Pap smear tests”. The differences are due to changes in the external and internal structure of the cervical tissue cells. The same holds for other physiological changes in the tissues - including folliculogenesis and pregnancy. Note these key words in the titles of randomly selected 3 publications: 1. impedance of the cervix in non-pregnant and pregnant women 2. cervical impedance in the prediction of the course and outcome of labor 3. uterine and cervical electromyography in monitoring pregnant patients Conclusion of publication #3: The potential benefits include… a reduction in the rate of preterm birth, improved maternal and perinatal outcome, better monitoring of treatment…

4 It tracks folliculogenesis in vivo (FIV™) What does Ovulona™ do? Ovulona™ Personal Fertility Smart Sensor Photo of a rapid prototyping model Note: This is not a real prototype. Real details are not shown. The planned internally worn telemetric cervical ring is not shown either. Folliculogenesis is central to women’s health, well-being, and lifestyle.

5 What Is Folliculogenesis? The biological foundation of a woman’s well-being.

6 For birth control, avoid insemination during these 3 days What FIV ™ does for women and for familyplanning Detecting the 3-day fertile window for getting pregnant

7 Different peak sizes show the different speed of maturation of the egg in different menstrual cycles (maturation of dominant follicle) Ovulation is detected as estrogen dominance switches to progesterone dominance This is the ovarian “I am ready” signal These are follicular waves preparing for the next cycle. They relate to how fast the woman approaches menopause. They disappear upon conception. Unprecedented wealth of information inherent in the signature FIV™ cyclic profile

8 Technology Overview Disruptive technology – FOLLICULOGENESIS IN VIVO™ Designed to improve quality and reduce costs of women’s reproductive and general health - from adolescence to menopause: - Help women to conceive - Help plan baby’s gender - Built-in detection of pregnancy and Early Pregnancy Loss - Forecast Expected Date of Delivery - Help with natural birth control - Help manage other conditions such as:  menstrual cramps  PMS  menopause  screen for cervical cancer, STDs

9 Transformational Technology Unprecedented accuracy Clear diagnostic indications – no guessing Easy to use Automatically detects & monitors pregnancy, computes Expected Delivery Date Automatically screens for cervical cancer, STDs Requires no chemical work, no graphing, no interpretation of data by the user Provides folliculogenesis profile history data to healthcare system MOSTLY BOYS BORN 77% MOSTLY GIRLS BORN 69%

10 Absence of the peaks anticipates failure to ovulate. Ovulona anticipates LPD = Luteal Phase Defect, which often causes failure to conceive by healthy women Ovulona’s diagnostic power will save healthcare costs This cannot be matched by ovulation kits or by any other such product

11 Ovulation prediction products

12 Comparison of technologies in the trying-to-conceive self-help market This is Ovulona monitor’s first application, FDA-ready for market CharacteristicsOvulona™ BBT Thermo meters LH kits urine chemistry Saliva magnifying glasses Body fluid Conductivity AccuracyHigh Low ReliabilityHigh Low Immediacy of resultsYes NoYesNo Convenience of useYes No YesNo Low cost of ownershipYes NoYes Information contentHigh Low Can be used for birth control?Yes No Can be used to preselect baby’s sex?Yes No Can it do built-in pregnancy check?Yes No Can it compute date of delivery?Yes No Folliculogenesis profile for healthcare?Yes No Multi-purpose long-term use?Yes No The Ovulona provides the most value, the most quality per dollar spent


Download ppt "Vaclav Kirsner, PhD, Founder CEO bioZhena Corporation (970) 484-1272 Transforming Female Reproductive Health."

Similar presentations


Ads by Google